Other news to note for Aug. 12, 2021

Antheia Inc., of Menlo Park, Calif., and Ginkgo Bioworks Inc., of Boston, are partnering to accelerate development and production of active pharmaceutical ingredients and key starting materials. Antheia plans to use Ginkgo's high throughput enzyme design and screening capabilities to broaden its pipeline of products. Financial terms of the collaboration weren’t disclosed.

Read the article at BioWorld